Steward Partners Investment Advisory’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,378
Closed -$28K 3406
2022
Q1
$28K Sell
1,378
-1,038
-43% -$21.1K ﹤0.01% 2212
2021
Q4
$70K Buy
2,416
+57
+2% +$1.63K ﹤0.01% 1749
2021
Q3
$51K Buy
2,359
+1,383
+142% +$33.4K ﹤0.01% 1888
2021
Q2
$25K Hold
976
﹤0.01% 4733
2021
Q1
$17.8K Buy
976
+145
+17% +$2.41K ﹤0.01% 2529
2020
Q4
$10K Buy
+831
New +$7.6K ﹤0.01% 2330
2020
Q1
Sell
-286
Closed -$2K 2733
2019
Q4
$2K Sell
286
-5
-2% -$29 ﹤0.01% 2463
2019
Q3
$1K Hold
291
﹤0.01% 2565
2019
Q2
$1K Buy
+291
New +$1.2K ﹤0.01% 2563
2018
Q4
Sell
-286
Closed -$2K 2249
2018
Q3
$2K Buy
+286
New +$1.7K ﹤0.01% 2423

Other funds holding CDMO

Steward Partners Investment Advisory's CDMO Position: Q2 2022 in Review

Steward Partners Investment Advisory sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2022, closing a stake of 1,378 shares — an estimated $28K sold.

Steward Partners Investment Advisory first reported a position in CDMO in Q3 2018 and held it in 10 quarters. The position peaked at $70K in Q4 2021. 187 funds tracked by Wall St. Rank hold CDMO as of Q2 2022.

  • Steward Partners Investment Advisory reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,378 Avid Bioservices, Inc. Common Stock shares in Q2 2022, an estimated $28K.
  • Steward Partners Investment Advisory first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 10 quarters.
  • Steward Partners Investment Advisory's Avid Bioservices, Inc. Common Stock position peaked at $70K in Q4 2021.
  • 187 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2022, filed 4 Aug 2022.